XOMA Plans Public Offering Of 9M Shares Following Panel Nod Sep. 12, 2003 By Aaron Lorenzo No Comments Two days after an FDA advisory panel recommended approval of its partnered psoriasis drug Raptiva, XOMA Ltd. disclosed plans for a public offering of 9 million common shares. (BioWorld Today)Read More
Vion Completes $11.3M Financing, Secures Operations Through 2004 Sep. 11, 2003 By Aaron Lorenzo No Comments
Chimerix Receives $36.1M Grant For Smallpox Drug Development Sep. 11, 2003 By Aaron Lorenzo No Comments
Chimerix Receives $36.1M Grant For Smallpox Drug Development Sep. 11, 2003 By Aaron Lorenzo No Comments
Vion Completes $11.3M Financing, Secures Operations Through 2004 Sep. 11, 2003 By Aaron Lorenzo No Comments
Therion Raises $39M To Expand Operations For Vaccine Products Sep. 10, 2003 By Aaron Lorenzo No Comments
Therion Raises $39M To Expand Operations For Vaccine Products Sep. 10, 2003 By Aaron Lorenzo No Comments
Incyte's Evolution Continues As It Licenses Late-Stage HIV Drug Sep. 9, 2003 By Aaron Lorenzo No Comments
Incyte's Evolution Continues As It Licenses Late-Stage HIV Drug Sep. 9, 2003 By Aaron Lorenzo No Comments
Pozen Licenses MT 300 Rights To Xcel In Deal Worth At Least $10M Sep. 5, 2003 By Aaron Lorenzo No Comments
